<p>Figures in brackets represent lower and upper quartile limits.</p><p>Abbreviations: ADAP: Antidepressant and antipsychotic/antimanic drugs; p = p-value; H<sub>0</sub> = Null Hypothesis, H<sub>1</sub> = Alternative Hypothesis; M<sub>T</sub> = the average duration of a LOT in TRD episodes, M<sub>N</sub> = the average duration of a LOT in non-TRD episodes; LOT = Line of therapy.</p>a<p>An episode will have at least 3 lines of treatment to qualify as TRD, based on the definition stated in the Methods section.</p
OBJECTIVE: To assess the economic impact of the duration of antidepressant drug treatment in a real-...
<p>Striatal D2/3 receptor (D2/3R) availability of TRD patients, TRD patients with antipsychotics (TR...
<p>Clinical statistics of the time frame of ALS-like symptoms with corresponding treatment doses.</p
<p>Abbreviations: p = p-value, H<sub>0</sub> = Null Hypothesis, H<sub>1</sub> = Alternative Hypothes...
<p>Note: ‘AD – Others’ includes alpha-2 receptor antagonists (tetracyclics), modified cyclics, tricy...
<p>Distribution of episodes by number of lines of treatment contained therein, compared for TRD and ...
<p>Note: ‘AD – Others’ includes alpha-2 receptor antagonists (tetracyclics), modified cyclics, tricy...
<p>(A) Duration of initial intensive phase in all patients (reference group 1.0–2.5 mo). (B) Duratio...
<p>The first row (A, D) of panels shows the duration of depressive episodes for the low-risk subpopu...
A1) treatments that enhance CNS inhibitory activity can abolish the depressed fixed point. A2) brief...
<p>Box plots of the distribution of the duration of antibiotic (AB) treatment (in days) for children...
a<p>Treatment duration = [(the study treatment end date)−(the first study drug start date)+1]/7.</p>...
<p>The first row of panels shows the results of simulations for the low-risk sub-population where th...
<p><sup>1</sup> Excludes patients who died on therapy or within 2 days of stopping.</p
AIMS: To compare health care resource utilization (HCRU), short-term disability days, and costs betw...
OBJECTIVE: To assess the economic impact of the duration of antidepressant drug treatment in a real-...
<p>Striatal D2/3 receptor (D2/3R) availability of TRD patients, TRD patients with antipsychotics (TR...
<p>Clinical statistics of the time frame of ALS-like symptoms with corresponding treatment doses.</p
<p>Abbreviations: p = p-value, H<sub>0</sub> = Null Hypothesis, H<sub>1</sub> = Alternative Hypothes...
<p>Note: ‘AD – Others’ includes alpha-2 receptor antagonists (tetracyclics), modified cyclics, tricy...
<p>Distribution of episodes by number of lines of treatment contained therein, compared for TRD and ...
<p>Note: ‘AD – Others’ includes alpha-2 receptor antagonists (tetracyclics), modified cyclics, tricy...
<p>(A) Duration of initial intensive phase in all patients (reference group 1.0–2.5 mo). (B) Duratio...
<p>The first row (A, D) of panels shows the duration of depressive episodes for the low-risk subpopu...
A1) treatments that enhance CNS inhibitory activity can abolish the depressed fixed point. A2) brief...
<p>Box plots of the distribution of the duration of antibiotic (AB) treatment (in days) for children...
a<p>Treatment duration = [(the study treatment end date)−(the first study drug start date)+1]/7.</p>...
<p>The first row of panels shows the results of simulations for the low-risk sub-population where th...
<p><sup>1</sup> Excludes patients who died on therapy or within 2 days of stopping.</p
AIMS: To compare health care resource utilization (HCRU), short-term disability days, and costs betw...
OBJECTIVE: To assess the economic impact of the duration of antidepressant drug treatment in a real-...
<p>Striatal D2/3 receptor (D2/3R) availability of TRD patients, TRD patients with antipsychotics (TR...
<p>Clinical statistics of the time frame of ALS-like symptoms with corresponding treatment doses.</p